ifosfamide has been researched along with Esophageal Neoplasms in 20 studies
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "25 previously untreated patients with inoperable or metastatic adenocarcinoma of the oesophagus or oesophageal-gastric junction area were treated with ifosfamide 6 g/m2 over 48 hours, combined with mesna 6 g/m2." | 7.68 | Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group. ( Kok, TC; Splinter, TA; Tilanus, HW; van der Gaast, A, 1991) |
| "We have reported the results of a previous Phase II trial of two courses of neoadjuvant mitomycin (6 mg/m2), ifosfamide (3 g/m2) and cisplatin (50 mg/m2) (MIC) in squamous or anaplastic carcinoma of the oesophagus." | 5.08 | A phase II trial of four courses of preoperative chemotherapy in squamous or anaplastic carcinoma of the oesophagus. ( Cullen, MH; Darnton, SJ; Matthews, HR; McAleer, JA; McManus, KG; Steyn, RS, 1998) |
| " We report a patient who was cured of metastatic adenocarcinoma in Barrett's oesophagus by six courses of ifosfamide, a chemotherapeutic agent with little or no activity in other patients with adenocarcinoma of the oesophagus or gastro-oesophageal junction." | 3.71 | Cure of Barrett's carcinoma by ifosfamide chemotherapy. ( Hage, M; Kok, TC; Kuipers, EJ; Siersema, PD; Tilanus, HW; van Dekken, H; van der Gaast, A, 2002) |
| "The multidrug resistance gene product P-glycoprotein (P-GP) was assessed immunohistochemically (by antibody JSB-1) in biopsy specimens from 27 oesophageal squamous carcinomas and 10 adenocarcinomas before treatment with mitomycin, ifosfamide and cisplatin (MIC)." | 3.69 | Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer. ( Darnton, SJ; Ferry, DR; Jenner, K; Matthews, HR; Steyn, RS, 1995) |
| "Of 13 patients with adenocarcinoma treated with 5-fluorouracil, adriamycin, and mitomycin (FAM), nine showed minor histological changes compared with 14 control cases." | 3.68 | Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. ( Allen, SM; Darnton, SJ; Edwards, CW; Matthews, HR, 1993) |
| "Ten resected oesophageal adenocarcinomas treated with preoperative chemotherapy--mitomycin-C, ifosfamide, and cisplatin (MIC)--were examined by transmission electron microscopy and their appearance compared with that of 13 concurrent untreated resected oesophageal adenocarcinomas." | 3.68 | Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma. ( Antonakopoulos, GN; Darnton, SJ; Matthews, HR; Newman, J, 1992) |
| "25 previously untreated patients with inoperable or metastatic adenocarcinoma of the oesophagus or oesophageal-gastric junction area were treated with ifosfamide 6 g/m2 over 48 hours, combined with mesna 6 g/m2." | 3.68 | Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group. ( Kok, TC; Splinter, TA; Tilanus, HW; van der Gaast, A, 1991) |
| "Grade 3/4 neutropenia was observed in 21 % of patients and grade 3/4 febrile neutropenia was seen in only one patient." | 2.73 | Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma. ( Ahn, JS; Ahn, MJ; Hwang, IG; Im, YH; Kang, WK; Lee, SC; Lim, HY; Park, BB; Park, K, 2008) |
| "Neo-adjuvant therapy with MIC in squamous carcinoma of the oesophagus has shown encouraging early results, with acceptable toxicity." | 2.67 | A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus. ( Allen, SM; Cullen, MH; Darnton, SJ; Duffy, JP; Matthews, HR; Walker, SJ, 1994) |
| "Esophageal cancer is the ninth most common malignancy in the world and the seventh leading cause of death in American men." | 2.43 | Docetaxel in the treatment of esophageal cancer. ( Bubis, JA; Dragnev, KH; Rigas, JR, 2005) |
| "The mainstay of curative treatment for oesophageal cancer is currently surgery with neoadjuvant chemotherapy or radiotherapy." | 1.31 | Curing oesophageal cancer: one swallow does not make a summer. ( Anderson, MR; Jankowski, JA, 2002) |
| "Seven oesophageal squamous carcinomas, treated with pre-operative chemotherapy (mitomycin-C, ifosfamide and cisplatin-MIC), with a course finishing 21 days prior to resection, were examined by electronmicroscopy." | 1.29 | Effects of chemotherapy on ultrastructure of oesophageal squamous cell carcinoma. ( Antonakopoulos, GN; Darnton, SJ; Duffy, JP; Matthews, HR; Newman, J, 1994) |
| "Ifosfamide has minimal activity in esophageal cancer and causes severe myelosuppression." | 1.27 | Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity. ( Eisenberger, M; Kelsen, DP; Lipperman, R; Nanus, DM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 9 (45.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallo, K | 1 |
| Brickman, A | 1 |
| Warren, WH | 1 |
| Gattuso, P | 1 |
| Seder, CW | 1 |
| Blot, E | 1 |
| Decaudin, D | 1 |
| Veyradier, A | 1 |
| Bardier, A | 1 |
| Zagame, OL | 1 |
| Pouillart, P | 1 |
| Anderson, MR | 1 |
| Jankowski, JA | 1 |
| Siersema, PD | 2 |
| Hage, M | 2 |
| van der Gaast, A | 2 |
| van Dekken, H | 2 |
| Kok, TC | 2 |
| Tilanus, HW | 2 |
| Kuipers, EJ | 1 |
| Darnton, SJ | 9 |
| Archer, VR | 2 |
| Stocken, DD | 2 |
| Mulholland, PJ | 2 |
| Casson, AG | 1 |
| Ferry, DR | 3 |
| Rigas, JR | 1 |
| Dragnev, KH | 1 |
| Bubis, JA | 1 |
| Park, BB | 1 |
| Im, YH | 1 |
| Hwang, IG | 1 |
| Lee, SC | 1 |
| Ahn, JS | 1 |
| Ahn, MJ | 1 |
| Lim, HY | 1 |
| Kang, WK | 1 |
| Park, K | 1 |
| Antonakopoulos, GN | 2 |
| Newman, J | 2 |
| Duffy, JP | 3 |
| Matthews, HR | 7 |
| Allen, SM | 3 |
| Walker, SJ | 1 |
| Cullen, MH | 3 |
| Edwards, CW | 1 |
| Jenner, K | 1 |
| Steyn, RS | 2 |
| Sur, M | 1 |
| Taylor, L | 1 |
| Cooper, K | 1 |
| Sur, RK | 1 |
| McManus, KG | 1 |
| McAleer, JA | 1 |
| Splinter, TA | 1 |
| Ansell, SM | 1 |
| Alberts, AS | 1 |
| Falkson, G | 1 |
| Nanus, DM | 1 |
| Kelsen, DP | 1 |
| Lipperman, R | 1 |
| Eisenberger, M | 1 |
1 review available for ifosfamide and Esophageal Neoplasms
| Article | Year |
|---|---|
Docetaxel in the treatment of esophageal cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cap | 2005 |
6 trials available for ifosfamide and Esophageal Neoplasms
| Article | Year |
|---|---|
Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2003 |
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Di | 2008 |
A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophagea | 1994 |
Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 1996 |
A phase II trial of four courses of preoperative chemotherapy in squamous or anaplastic carcinoma of the oesophagus.
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Al | 1998 |
Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisp | 2001 |
13 other studies available for ifosfamide and Esophageal Neoplasms
| Article | Year |
|---|---|
Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; H | 2015 |
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
Topics: ADAM Proteins; ADAMTS13 Protein; Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemothe | 2002 |
Curing oesophageal cancer: one swallow does not make a summer.
Topics: Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Esophageal Neo | 2002 |
Cure of Barrett's carcinoma by ifosfamide chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Barrett Esophagus; Esophageal Neoplasms; Fo | 2002 |
Cure of Barrett's carcinoma by ifosfamide chemotherapy.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Esophageal Neoplasms; Humans; Ifosfamide; Kera | 2003 |
Effects of chemotherapy on ultrastructure of oesophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 1994 |
Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1993 |
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Tr | 1995 |
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Membe | 1997 |
Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleolus; Cisplat | 1992 |
Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group.
Topics: Adenocarcinoma; Adult; Aged; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Ifosfam | 1991 |
Ifosfamide in advanced carcinoma of the esophagus: a phase II trial with severe toxicity.
Topics: Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Esophageal Neoplasms; Femal | 1989 |
Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Esophageal Neoplasms; Female; Hematologic Te | 1988 |